Sign In
Buy SILK
$27.49
+0 (+0%)
At Close: Dec 13, 2024
Boston Scientific Announces Results for Third Quarter 2024
06:30am, Wednesday, 23'rd Oct 2024
MARLBOROUGH, Mass. , Oct. 23, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.209 billion during the third quarter of 2024, growing 19.4 percent on a reported
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
08:31am, Tuesday, 17'th Sep 2024
MARLBOROUGH, Mass. , Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: SILK), a medical device
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY and SILK on Behalf of Shareholders
10:15am, Thursday, 22'nd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or bre
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS
NEW YORK , Aug. 20, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securit
SILK Alert: Monsey Firm of Wohl & Fruchter Renews Investigation of the Proposed Sale of Silk Road Medical to Boston Scientific
09:31am, Monday, 19'th Aug 2024
MONSEY, N.Y., Aug. 19, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP has renewed its investigation into the fairness of the proposed sale of Silk Road Medical, Inc. (Nasdaq: SILK) (“S
Silk Road Medical (SILK) Reports Q2 Loss, Tops Revenue Estimates
07:11pm, Wednesday, 07'th Aug 2024
Silk Road Medical (SILK) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.35 per share a year ago.
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
08:00am, Tuesday, 30'th Jul 2024
Studied across thousands of patients and supported by hundreds of clinical publications, the TCAR pioneer has continually delivered positive outcomes through minimally invasive techniques
SILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger of Silk Road Medical, Inc.
08:30am, Monday, 29'th Jul 2024
NEW YORK , July 29, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securit
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc. – SILK
05:16pm, Tuesday, 16'th Jul 2024
NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc. - SILK
02:35pm, Monday, 15'th Jul 2024
NEW YORK , July 15, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securit
SILK Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Silk Road Medical to Boston Scientific
09:10am, Monday, 24'th Jun 2024
MONSEY, N.Y., June 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $27.50 per share in cash for which Silk Road Medical, Inc. (Nasdaq: SI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Silk Road Me
Strength Seen in Silk Road Medical (SILK): Can Its 24.0% Jump Turn into More Strength?
05:25am, Wednesday, 19'th Jun 2024
Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price in
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.
01:23pm, Tuesday, 18'th Jun 2024
NEW YORK , June 18, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Silk Road Medical, Inc. (NASDAQ: SILK) and its board of directors concerning the propos
